World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
118
Citations
44626
World Ranking
360
National Ranking
229

Medicine

D-Index
118
Citations
44763
World Ranking
4089
National Ranking
2244

James I. Mullins publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where James I. Mullins sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 459 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

James I. Mullins D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where James I. Mullins sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 118 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

James I. Mullins is affiliated with the University of Washington in the United States. Their research centers primarily on HIV, focusing on areas such as HIV research and treatment, HIV/AIDS drug development and treatment, and HIV/AIDS research and interventions. Their expertise also extends into related immunological fields, including immune cell function and interaction, immunotherapy and immune responses, and viral-associated cancers and disorders.

Their main fields of study encompass Medicine and Immunology and Microbiology, with significant contributions to subfields like Virology, Infectious Diseases, Immunology, Molecular Biology, and Epidemiology.

James I. Mullins has contributed to various research papers, with notable publications including the full titles, years, and venues listed below:

  • Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition, 2022, Nature Medicine
  • In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia, 2021, Nature Communications
  • Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials, 2023, PLoS Pathogens
  • Droplet-microfluidics-assisted sequencing of HIV proviruses and their integration sites in cells from people on antiretroviral therapy, 2022, Nature Biomedical Engineering
  • Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment, 2020, PLoS Pathogens

Their frequent co-authors include:

  • Carolyn Williamson
  • Allan C. deCamp
  • Peter B. Gilbert
  • Michal Juraska
  • Lawrence Corey

James I. Mullins's work has been published across several venues repeatedly. The most frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • PLoS Pathogens
  • Nature Communications
  • Virus Evolution

Best Publications

  • CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

    Photini Kiepiela;Kholiswa Ngumbela;Christina Thobakgale;Dhanwanthie Ramduth

  • Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection

    Raj Shankarappa;Joseph B. Margolick;Stephen J. Gange;Allen G. Rodrigo

  • Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

    Photini Kiepiela;Alasdair J. Leslie;Isobella Honeyborne;Danni Ramduth

  • Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes

    Eric L. Delwart;Eugene G. Shpaer;Joost Louwagie;Francine E. McCutchan

  • Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection

    Thor A. Wagner;Sherry McLaughlin;Sherry McLaughlin;Kavita Garg;Charles Y. K. Cheung

  • Photonic detection of bacterial pathogens in living hosts

    Christopher H. Contag;Pamela R. Contag;James I. Mullins;James I. Mullins;Stanley D. Spilman

  • Persistence of HIV in Gut-Associated Lymphoid Tissue despite Long-Term Antiretroviral Therapy

    Tae Wook Chun;David C. Nickle;Jesse S. Justement;Jennifer H. Meyers

  • The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

    W. Andiman;M. Boucher;D. Burns;Y. Bryson

  • Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.

    C. Celum;A. Wald;A. Wald;J.R. Lingappa;A.S. Magaret;A.S. Magaret

  • Molecular Epidemiology of HIV Transmission in a Dental Practice

    Chin-Yih Ou;Carol A. Ciesielski;Gerald Myers;Claudiu I. Bandea

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1

    Javier Martinez-Picado;Julia G. Prado;Elizabeth E. Fry;Katja Pfafferott

  • Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

    Tae Wook Chun;Richard T. Davey;Mario Ostrowski;J. Shawn Justement

  • Improved Coreceptor Usage Prediction and Genotypic Monitoring of R5-to-X4 Transition by Motif Analysis of Human Immunodeficiency Virus Type 1 env V3 Loop Sequences

    Mark A. Jensen;Fu Sheng Li;Angélique B. Van 't Wout;David C. Nickle

  • Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection

    Marcus Altfeld;Eric S. Rosenberg;Raj Shankarappa;Joia S. Mukherjee

  • Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA

    Camille Sureau;Jean Loup Romet-Lemonne;James I. Mullins;Max Essex

  • Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

    Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra

  • Antibodies to cell membrane antigens associated with human T-cell leukemia virus in patients with AIDS

    M. Essex;M. F. McLane;T. H. Lee;L. Falk

  • Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Lawrence Corey;Peter B Gilbert;Michal Juraska;David C Montefiori

  • Lethal mutagenesis of HIV with mutagenic nucleoside analogs.

    Lawrence A. Loeb;John M. Essigmann;Farhad Kazazi;Jue Zhang

  • Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.

    Tuofu Zhu;David Muthui;Sarah Holte;David Nickle

  • Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.

    Eric L. Delwart;Haynes W. Sheppard;Bruce D. Walker;Jaap Goudsmit

  • Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission

    Jared M. Baeten;Erin Kahle;Jairam R. Lingappa;Robert W. Coombs

Frequent Co-Authors

Bruce D. Walker
Bruce D. Walker Harvard University
Gerald H. Learn
Gerald H. Learn University of Pennsylvania
Morgane Rolland
Morgane Rolland Henry M. Jackson Foundation
David C. Nickle
David C. Nickle Monoceros Biosystems
Philip J. R. Goulder
Philip J. R. Goulder University of Oxford
Lawrence Corey
Lawrence Corey Fred Hutchinson Cancer Research Center
Lisa M. Frenkel
Lisa M. Frenkel University of Washington
Edward A. Hoover
Edward A. Hoover Colorado State University
M. Juliana McElrath
M. Juliana McElrath University of Washington
Bette T. Korber
Bette T. Korber Los Alamos National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open doors to dynamic healthcare careers. Many professionals transition into specialized nursing roles where understanding the immune system is crucial. For example, accelerated nurse practitioner programs offer a fast track to advanced practice, combining clinical expertise with leadership skills. Interested students can find reputable options by searching for nurse practitioner accelerated program opportunities online.

Non-nurses eager to enter the healthcare field can consider enrolling in online BSN programs for non nurses. These programs provide foundational nursing education with flexible scheduling, making them suitable for career changers.

For those seeking quicker entry into nursing, exploring the easiest accelerated nursing programs to get into can be beneficial. These programs cater to students aiming for efficiency without compromising education quality. More details can be found by looking up easiest accelerated nursing programs to get into.

Additionally, practical nursing roles remain in high demand, and the fastest and easiest LPN programs provide a gateway to the profession with minimal time investment. Prospective students should research available options by considering fastest and easiest lpn programs to find the best fit.

Best Scientists Citing James I. Mullins

Trending Scientists

Recently Published Articles